BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
What was lobbied
17 issue areas, each in the filer's own words, with who lobbied on it and where.
Agriculture AGR
EPA Regulations on Agricultural Biotechnology --Pesticide Registration Improvement Act Reauthorization Livestock Cloning/Product Labeling --Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals --Labeling --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ---Amendment on GE Salmon Labeling Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for the USDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Foreign Agricultural Biotechnology Laws and Regulations --Asynchrony of International Approvals --China Biotechnology Regulations --EU Ag-Biotech Policies and Regulations Potential Regulation of New Genetic Modification Technologies USDA/APHIS Agricultural Biotechnology Regulations --Efficient Science-Based Review of Biotech Products International Treaty on Plant Genetic Resources Review of the Federal Coordinated Framework for Biotechnology Products
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN T BAENIG New | LA,Sen Wellstone,5-1-1998-12-31-02;Staff, Sen Jud. Cmt,7-1-03-5-31-05; Sr Policy Adv,Sen Leahy,6-1-05-9-31-09; Dep Staff Dir., Sen Ag Cmt.,10-1-09-2-28-11; Dep Undersec.,USDA, 3-1-11-9-30-11; Asst Sec,USDA 10-1-11-8-31-13; CoS, USDA,9-1-13-8-31-15 |
| TOM DILENGE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Budget/Appropriations BUD
Funding for the USDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for FDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for the National Institutes of Health --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Centers for Disease Control and Prevention Vaccine Programs --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Renewable Chemicals/Bio-based Products --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --H.R. 2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Section 9003 Funding for Biofuels --H.R. 2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Sequestration of PDUFA Fees --S. 1413: FDA User Fee Protection Act --HR 2725: Food and Drug Administration Safety over Sequestration Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| KELLY CAPPIO | — |
| ANDREW EMMETT | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| RINA SINGH | — |
| AMY WALKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Animals ANI
Livestock Cloning/Product Labeling --Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals --Labeling --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ---Amendment on GE Salmon Labeling
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN T BAENIG New | LA,Sen Wellstone,5-1-1998-12-31-02;Staff, Sen Jud. Cmt,7-1-03-5-31-05; Sr Policy Adv,Sen Leahy,6-1-05-9-31-09; Dep Staff Dir., Sen Ag Cmt.,10-1-09-2-28-11; Dep Undersec.,USDA, 3-1-11-9-30-11; Asst Sec,USDA 10-1-11-8-31-13; CoS, USDA,9-1-13-8-31-15 |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Science/Technology SCI
Synthetic Biology --H.R. 591: Engineering Biology Research and Development Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TOM DILENGE | — |
| JEANNE HAGGERTY | — |
| DANA MAURICE O'BRIEN | — |
Trade (domestic/foreign) TRD
Biosimilars --Colombia Biologics Regulations Foreign Agricultural Biotechnology Laws and Regulations --Asynchrony of International Approvals --China Biotechnology Regulations --EU Ag Biotech Policies and Regulations TransPacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals --Regulatory Transparency Transatlantic Trade and Investment Partnership --Intellectual Property Issues --Regulatory Harmonization International Treaty on Plant Genetic Resources Intellectual Property International Enforcement --India
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| NICK MAGALLANES New | LC/LA, Sen. Alexander, 1-19-10-3-1-12; LA, Rep. Terry, 4-1-12-3-16-14; Staff Member, Energy & Commerce Cmt., 12-31-12-3-16-14; Health Policy Adv., Rep. Rodgers, 3-17-14-9-18-15; Sr. Adv., House Rep. Conf., 9-30-14-9-18-15 |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| DERRICK M WHITE | — |
Taxation/Internal Revenue Code TAX
Renewable Chemicals/Bio-based Products --Expansion of Master Limited Partnerships to Renewable Chemicals --New Production Tax Credit --S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act --H.R. 2833/S.1656: Master Limited Partnerships Parity Act of 2015 Biofuels --Production Tax Credit Extension --S.2089: American Energy Innovation Act Research & Development Tax Credit Reforms --Extension --Permanency --Refundable R&D Credit --H.R.880: To amend the Internal Revenue Code to make permanent the credit for increasing research activities --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act Capital Formation Investment Incentives --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act --H.R. 2179: PARTNER Act Tax Reform --Innovation Box/Patent Box Orphan Drug Act Tax Credit Inversions --H.R. 2995/S.1910: Department of Financial Services and Related Agencies Appropriations Act for FY 2016 Antibiotic & Diagnostic Tax Credit --H.R. 3539: Antibiotic & Diagnostic Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY CAPPIO | — |
| CHARLES CRAIN | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| SHELLY MUI-LIPNIK | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Copyright/Patent/Trademark CPT
Patent Reform --H.R. 9: Innovation Act --S.1137: Protecting American Talent and Entrepreneurship Act of 2015 --Implementation of the America Invents Act of 2011 TransPacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals --Regulatory Transparency Transatlantic Trade and Investment Partnership --Intellectual Property Issues Drug Patent Settlements --S.1137: Protecting American Talent and Entrepreneurship Act of 2015 --S. 2019: Preserve Access to Affordable Generics Act of 2015 Inter Partes Review --Implementation of the American Invents Act of 2011 --S. 632: STRONG Patents Act --S. 1137: Protecting American Talent and Entrepreneurship Act of 2015 --H.R. 9: Innovation Act Intellectual Property International Enforcement --India
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| TRACEY LATURNER | — |
| NICK MAGALLANES New | LC/LA, Sen. Alexander, 1-19-10-3-1-12; LA, Rep. Terry, 4-1-12-3-16-14; Staff Member, Energy & Commerce Cmt., 12-31-12-3-16-14; Health Policy Adv., Rep. Rodgers, 3-17-14-9-18-15; Sr. Adv., House Rep. Conf., 9-30-14-9-18-15 |
| DANA MAURICE O'BRIEN | — |
| HANSJORG SAUER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Health Issues HCR
Biosimilars --Biosimilar User Fee Act Implementation --Coding --Colombia Biologics Regulations --Implementation of Affordable Care Act --Interchangeability and Pharmacy Substitution --Naming --Reimbursement Policy Funding for Centers for Disease Control and Prevention Vaccine Programs --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Vaccine Access/Financing 340B Drug Pricing Program --Program Implementation & Oversight --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Medicaid Pricing and Rebates --Average Manufacturer Price Calculations Diagnostics and Personalized Medicine Regulation and Oversight Funding for FDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Biodefense Research, Development and Procurement Issues (Non-funding) TransPacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals --Regulatory Transparency Transatlantic Trade and Investment Partnership --Intellectual Property Issues --Regulatory Harmonization Reimbursement for Innovative Products --Medicare Part D Prescription Drug Program --Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees --S. 1413: FDA User Fee Protection Act --HR 2725: Food and Drug Administration Safety over Sequestration Act of 2015 Drug Evaluation and Review --Compassionate Use/Expanded Access --Implementation of the FDA Safety and Innovation Act Orphan Drug Act Tax Credit Senate Innovation for Healthier Americans Initiative --Biomarkers and Regulatory Science Improvements --Combination Products --Communication with Healthcare Professionals --Expanded Access to Investigational Drugs --Expedited Pathways --FDA Hiring Flexibility --FDA Management and Financial Accountability --Information Disclosures --Innovation Incentives --Longitudinal Study of Chronic Diseases --Patient Access to Approved Drugs --Patient-Focused Drug Development --Use of Real-World Evidence --Vaccine and Anti-Microbial Resistance Product Development and Incentives --PATH Act (Senate Discussion Draft) House 21st Century Cures Initiative --Vaccine and Anti-Microbial Resistance Product Development and Incentives --ADAPT Act (House Discussion Draft) --Biomarkers and Regulatory Science Improvements --Communication with Healthcare Professionals --Expanded Access to Investigational Drugs --Expedited Pathways --FDA Hiring Flexibility --FDA Management and Financial Accountability --Innovation Incentives --Longitudinal Study of Chronic Diseases --Patient Access to Approved Drugs --Patient-Focused Drug Development --Use of Real-World Evidence Vaccines and Infectious Diseases - General Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Government Price Reporting --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Gene Editing Technologies --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 -----Report Language on Heritable Genetic Modification Restriction NIH Precision Medicine Initiative Antibiotic & Diagnostic Tax Credit --H.R. 3539: Antibiotic & Diagnostic Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| KELLY CAPPIO | — |
| JOSEPH DAMOND | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| ERIN ESTEY HERTZOG | — |
| KATHLEEN HOLCOMBE | — |
| TRACEY LATURNER | — |
| NICK MAGALLANES | LC/LA, Sen. Alexander, 1-19-10-3-1-12; LA, Rep. Terry, 4-1-12-3-16-14; Staff Member, Energy & Commerce Cmt., 12-31-12-3-16-14; Health Policy Adv., Rep. Rodgers, 3-17-14-9-18-15; Sr. Adv., House Rep. Conf., 9-30-14-9-18-15 |
| SHELLY MUI-LIPNIK | — |
| LAUREL TODD | — |
| AMY WALKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Small Business SMB
Sarbanes Oxley Section 404 (b) --Exemption for Emerging Companies Capital Formation Investment Incentives --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act --H.R. 2179: PARTNER Act Expansion of Exemption under SEC Regulation A --H.R. 1839: Reforming Access for Investments in Startup Enterprises (RAISE) Act Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions --Fostering Innovation Act (House Discussion Draft) XBRL Exemption for Small Public Companies --H.R. 1965: Small Company Disclosure Simplification Act Capital Market Enhancements --SEC Office of Small Business Policy Responsibilities --H.R. 1525: Disclosure Modernization and Simplification Act --H.R. 1675: Encouraging Employee Ownership Act --H.R. 1723: Small Company Simple Registration Act --H.R. 2064: Improving Access to Capital for Emerging Growth Companies Act --H.R. 2357: Accelerating Access to Capital Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES CRAIN | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| SHELLY MUI-LIPNIK | — |
Medicare/Medicaid MMM
Medicaid Pricing and Rebates --Average Manufacturer Price Calculations Reimbursement for Innovative Products --Medicare Part D Prescription Drug Program --Medicare Part B Physician-Administered Products House 21st Century Cures Initiative --Patient Access to Approved Drugs Senate Innovation for Healthier Americans Initiative --Patient Access to Approved Drugs Government Price Reporting --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| ERIN ESTEY HERTZOG | — |
| KATHLEEN HOLCOMBE | — |
| NICK MAGALLANES New | LC/LA, Sen. Alexander, 1-19-10-3-1-12; LA, Rep. Terry, 4-1-12-3-16-14; Staff Member, Energy & Commerce Cmt., 12-31-12-3-16-14; Health Policy Adv., Rep. Rodgers, 3-17-14-9-18-15; Sr. Adv., House Rep. Conf., 9-30-14-9-18-15 |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Chemicals/Chemical Industry CHM
Renewable Chemicals/Bio-based Products (Non-Funding) --S. 697: Chemical Safety for the 21st Century Act ----Nomenclature Usage ----Pre-market Notification Review --S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act --H.R. 2833/S.1656: Master Limited Partnerships Parity Act of 2015 --Expansion of Master Limited Partnerships to Renewable Chemicals --Implementation of the Agricultural Act of 2014, Section 9003 Funding for Renewable Chemicals/Bio-based Products --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --H.R. 2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Section 9003
| Lobbyist | Covered position, as disclosed |
|---|---|
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Consumer Issues/Safety/Products CSP
Livestock Cloning/Product Labeling --Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals --Labeling --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ---Amendment on GE Salmon Labeling Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Biosimilars --Colombia Biologics Regulations --Implementation of Affordable Care Act --Interchangeability and Pharmacy Substitution --Naming USDA/APHIS Agricultural Biotechnology Regulations --Efficient Science-Based Review of Biotech Products
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN T BAENIG New | LA,Sen Wellstone,5-1-1998-12-31-02;Staff, Sen Jud. Cmt,7-1-03-5-31-05; Sr Policy Adv,Sen Leahy,6-1-05-9-31-09; Dep Staff Dir., Sen Ag Cmt.,10-1-09-2-28-11; Dep Undersec.,USDA, 3-1-11-9-30-11; Asst Sec,USDA 10-1-11-8-31-13; CoS, USDA,9-1-13-8-31-15 |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| KATHLEEN HOLCOMBE | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Energy/Nuclear ENG
Biofuels (Non-Funding) --Production Tax Credit Extension --S.2089: American Energy Innovation Act Funding for Biofuels --H.R. 2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Renewable Fuel Standard (RFS) --Proposed Rule --S. 1372: American Crude Oil Export Equality Act ----Amendment to Repeal Conventional Biofuel Category of RFS --H.R. 702: A Bill to Adapt to Changing Crude Oil Market Conditions ---- Amendment to Repeal RFS
| Lobbyist | Covered position, as disclosed |
|---|---|
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Food Industry (safety, labeling, etc.) FOO
Livestock Cloning/Product Labeling --Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals --Labeling --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ----Amendment on GE Salmon Labeling Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN T BAENIG | LA,Sen Wellstone,5-1-1998-12-31-02;Staff, Sen Jud. Cmt,7-1-03-5-31-05; Sr Policy Adv,Sen Leahy,6-1-05-9-31-09; Dep Staff Dir., Sen Ag Cmt.,10-1-09-2-28-11; Dep Undersec.,USDA, 3-1-11-9-30-11; Asst Sec,USDA 10-1-11-8-31-13; CoS, USDA,9-1-13-8-31-15 |
| TOM DILENGE | — |
| JEANNE HAGGERTY | — |
| A. CATHARINE HARRIS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Fuel/Gas/Oil FUE
Biofuels (Non-Funding) --Production Tax Credit Extension --S.2089: American Energy Innovation Act Funding for Biofuels --H.R. 2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Renewable Fuel Standard (RFS) --Proposed Rule --S. 1372: American Crude Oil Export Equality Act ----Amendment to Repeal Conventional Biofuel Category of RFS --H.R. 702: A Bill to Adapt to Changing Crude Oil Market Conditions ----Amendment to Repeal RFS
| Lobbyist | Covered position, as disclosed |
|---|---|
| TOM DILENGE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ERICK LUTT | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Homeland Security HOM
Biodefense Research, Development and Procurement Issues (Non-funding) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Combating Antibiotic-Resistant Bacteria (CARB) Initiative --PATH Act (Senate Discussion Draft/Innovation for Healthier Americans Initiative) --ADAPT Act (House Discussion Draft/21st Century Cures Initiative)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| KELLY CAPPIO | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| NICK MAGALLANES New | LC/LA, Sen. Alexander, 1-19-10-3-1-12; LA, Rep. Terry, 4-1-12-3-16-14; Staff Member, Energy & Commerce Cmt., 12-31-12-3-16-14; Health Policy Adv., Rep. Rodgers, 3-17-14-9-18-15; Sr. Adv., House Rep. Conf., 9-30-14-9-18-15 |
| AMY WALKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| DERRICK M WHITE | — |
Medical/Disease Research/Clinical Labs MED
NIH Precision Medicine Initiative Funding for National Institutes of Health --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Biodefense Research, Development and Procurement Issues (Non-funding) House 21st Century Cures Initiative --Longitudinal Study of Chronic Diseases Senate Innovation for Healthier Americans Initiative --Longitudinal Study of Chronic Diseases Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| KELLY CAPPIO | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| JAMIE GREGORIAN | — |
| JEANNE HAGGERTY | — |
| KATHLEEN HOLCOMBE | — |
| TRACEY LATURNER | — |
| NICK MAGALLANES New | LC/LA, Sen. Alexander, 1-19-10-3-1-12; LA, Rep. Terry, 4-1-12-3-16-14; Staff Member, Energy & Commerce Cmt., 12-31-12-3-16-14; Health Policy Adv., Rep. Rodgers, 3-17-14-9-18-15; Sr. Adv., House Rep. Conf., 9-30-14-9-18-15 |
| AMY WALKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.